Objectives: To determine the ability of human mononuclear cells to pro
duce factors that cause catecholamine secretion from adrenomedullary c
hromaffin cells; to determine conditions that stimulate mononuclear ce
lls to produce such factors; and to compare these results with catecho
lamine secretion in response to the cytokines interleukin (IL)-1 and I
L-2. Design: Randomized, controlled, prospective study using in vitro
conditions. Setting: University research laboratory. Subjects: Human m
ononuclear cells and porcine chromaffin cells. Interventions: Circulat
ing human mononuclear cells were isolated and cultured overnight in RP
MI media. Cell-free media from these cultures (conditioned media) were
then tested for the ability to cause epinephrine secretion from porci
ne chromaffin cells. Mononuclear cells were stimulated with phytohemag
glutinin or by mixing cells from two different individuals while suppr
ession was tested with dexamethasone. Catecholamine secretion in respo
nse to IL-1 and IL-2 (50 and 500 units/well, respectively), or nicotin
ic agonist dimethylphenylpiperazinium (10 mu M, which mimics the actio
n of acetylcholine), was tested for comparison. Measurements and Main
Results: isolated porcine chromaffin cells had stable catecholamine co
ntent at the time of secretion measurements, and catecholamine release
from cells into the media was measured using electrochemical detectio
n after high-performance liquid chromatography separation, Catecholami
ne secretion was expressed as a percentage of the total cellular conte
nt, Epinephrine secretion due to human conditioned media was 6.9 +/- 1
,0% compared with 1.4 +/- 0.6% for control media (p < .05) and 14.6 +/
- 3.3% for dimethylphenylpiperazinium (p < .05), Epinephrine secretion
with conditioned media from mixed cells (mixed leukocyte reaction) wa
s 16.6 +/- 1.2%, which was higher than the epinephrine secretion cause
d by media from a single donor (6.9% +/- 1,0, p < .001). Pretreatment
with dexamethasone inhibited the formation of bioactive products from
mixed mononuclear cell preparations. Cytokines IL-1 and IL-2 did not s
timulate chromaffin cell epinephrine secretion above background releas
e with control media incubation, In all cases, norepinephrine secretio
n was similar to that of epinephrine, and results are included in all
figures. Conclusions: Factors released from human immune cells can med
iate epinephrine and norepinephrine release from adrenomedullary cells
through a nonneural mechanism. Suck immune cell factor release can be
modulated by immunostimulation and steroid suppression. Release of su
ch factors in vivo may contribute to increased circulating epinephrine
in response to infectious challenge and may be an important factor in
the critically ill patient.